SCHEMBL6177943

SCHEMBL6177943

Cc1ccc2c(c1)N(CC(=O)c1ccc(C)o1)C(=O)C(N)CN2C(=O)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.34
HTT P42858 4/20 0.34
NPSR1 Q6W5P4 3/20 0.34
MAPT P10636 3/20 0.34
PKM P14618 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 5/20 0.33
AADAT Q8N5Z0 2/20 0.33
CHRNB2 P17787 2/20 0.32
CHRNB4 P30926 2/20 0.32
CHRNA3 P32297 2/20 0.32
CHRNA4 P43681 2/20 0.32
CHRNA7 P36544 1/20 0.32
THRB P10828 2/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32
XBP1 P17861 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959681 0.83 CCKBR (0.35) CYP3A4
SCHEMBL6176995 0.82 TSHR (0.40) TSHRMAPTALDH1A1AADATTHRB
SCHEMBL6178413 0.80 ALDH1A1 (0.40) TSHRHTTNPSR1HPGDALDH1A1
SCHEMBL6209886 0.80 TSHR (0.35) TSHRALDH1A1AADATCYP1A2CYP2D6
SCHEMBL6178856 0.77 CCKBR (0.52)
SCHEMBL6180213 0.76 TSHR (0.38) TSHRMAPTALDH1A1THRBLMNA
SCHEMBL6180301 0.76 CCKBR (0.47) MAPTLMNATP53KMT2A
SCHEMBL6178279 0.72 CYP3A4 (0.37) TSHRMAPTALDH1A1AADATCYP1A2
SCHEMBL6177133 0.71 TSHR (0.41) TSHRMAPTALDH1A1THRBLMNA
SCHEMBL6179979 0.71 ALDH1A1 (0.44) ALDH1A1THRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed